CoChat

The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth

Alarcon, Guido, Nguyen, Anh, Jones, Angus, Shields, Beverley, Redondo, Maria J, Tosur, Mustafa · 2025 · The Journal of Clinical Endocrinology & Metabolism
Cited by 6

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Context: The applicability of the maturity-onset diabetes of the young (MODY) risk calculator to non-White European populations remains unknown. Objective: We aimed to test its real-world application in Hispanic youth. Methods: We conducted a retrospective chart review of Hispanic youth (<23 years) with diabetes (n = 2033) in a large pediatric tertiary care center in the United States. We calculated MODY probability for all subjects, splitting them into 2 cohorts based on the original model: individuals who were started on insulin within 6 months of diabetes diagnosis (Cohort 1) and those who were not (Cohort 2). Results: Cohort 1 consisted of 1566 individuals (median age [25p, 75p]: 16 [13, 19] years, 49% female), while Cohort 2 comprised 467 youth (median age [25p, 75p]: 17 [15, 20] years, 62% female). The mean MODY probability was 5.9% and 61.9% in Cohort 1 and Cohort 2, respectively. The mean probability for both cohorts combined was 18.8%, suggesting an expected 382 individuals with MODY, which is much higher than previous estimations (1-5%; ie, 20-102 individuals in this cohort). A total of 18 individuals tested positive for MODY among the limited number of individuals tested based on clinical suspicion and genetic testing availability (n = 44 out of 2033 tested, 2.2% of overall cohort). Conclusion: The MODY risk calculator likely overestimates the probability of MODY in Hispanic youth, largely driven by an overestimation in those not early-insulin treated (predominantly young-onset type 2 diabetes). The calculator needs updating to improve its applicability in this population. In addition, further research is needed to help better identify MODY in Hispanic youth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/clinem/dgae770

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 19

  1. Delvecchio, 2017, Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012, J Clin Endocrinol Metab, 102, 1826, 10.1210/jc.2016-2490 · DOI · Paper page
  2. Tosur, 2022, Precision diabetes: lessons learned from maturity-onset diabetes of the young (MODY), J Diabetes Investig, 13, 1465, 10.1111/jdi.13860 · DOI
  3. Shields, 2012, The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes, Diabetologia, 55, 1265, 10.1007/s00125-011-2418-8 · DOI · Paper page
  4. Johnson, 2019, Comprehensive genetic screening: the prevalence of maturity-onset diabetes of the young gene variants in a population-based childhood diabetes cohort, Pediatr Diabetes, 20, 57, 10.1111/pedi.12766 · DOI
  5. Fendler, 2012, Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign, Diabetologia, 55, 2631, 10.1007/s00125-012-2621-2 · DOI · Paper page
  6. Ehtisham, 2004, First UK survey of paediatric type 2 diabetes and MODY, Arch Dis Child, 89, 526, 10.1136/adc.2003.027821 · DOI · Paper page
  7. Candler, 2018, Continuing rise of type 2 diabetes incidence in children and young people in the UK, Diabet Med, 35, 737, 10.1111/dme.13609 · DOI · Paper page
  8. Lawrence, 2021, Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017, JAMA, 326, 717, 10.1001/jama.2021.11165 · DOI · Paper page
  9. Misra, 2016, South Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European people, Diabetologia, 59, 2262, 10.1007/s00125-016-4056-7 · DOI
  10. Zhu, 2019, Racial/ethnic disparities in the prevalence of diabetes and prediabetes by BMI: patient outcomes research to advance learning (PORTAL) multisite cohort of adults in the U. S, Diabetes Care, 42, 2211, 10.2337/dc19-0532 · DOI · Paper page
  11. Wang, 2020, Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic, Int J Epidemiol, 49, 810, 10.1093/ije/dyz273 · DOI · Paper page
  12. Zhao, 2024, MODY probability calculator is suitable for MODY screening in China: a population-based study, J Endocr Soc, 8, bvae047, 10.1210/jendso/bvae047 · DOI · Paper page
  13. Santomauro, 2023, The performance of the MODY calculator in a non-Caucasian, mixed-race population diagnosed with diabetes mellitus before 35 years of age, Diabetol Metab Syndr, 15, 15, 10.1186/s13098-023-00985-3 · DOI
  14. Keskinler, 2020, MODY probability ratios in patients diagnosed with type 2 diabetes Mellitus at a young age, Medeni Med J, 35, 290
  15. Harrington, 2023, Monogenic diabetes in New Zealand—an audit based revision of the monogenic diabetes genetic testing pathway in New Zealand, Front Endocrinol (Lausanne), 14, 1116880, 10.3389/fendo.2023.1116880 · DOI
  16. da Silva Santos, 2022, MODY probability calculator utility in individuals’ selection for genetic testing: its accuracy and performance, Endocrinol Diabetes Metab, 5, e00332, 10.1002/edm2.332 · DOI
  17. De Sousa, 2024, Identification of monogenic diabetes in an Australian cohort using the Exeter maturity-onset diabetes of the young (MODY) probability calculator and next-generation sequencing gene panel testing, Acta Diabetol, 61, 181, 10.1007/s00592-023-02193-x · DOI
  18. Tarantino, 2020, MODY probability calculator for GCK and HNF1A screening in a multiethnic background population, Arch Endocrinol Metab, 64, 17
  19. Hohendorff, 2019, The utility of MODY probability calculator in probands of families with early-onset autosomal dominant diabetes from Poland, Minerva Med, 110, 499

Cited by

See all 6

Metadata

Authors
Alarcon, G., Nguyen, A., Jones, A., Shields, B., Redondo, M. J., & Tosur, M.
Affiliations
  • Department of Pediatrics, The Division of Diabetes and Endocrinology, Baylor College of Medicine, Texas Children’s Hospital , Houston, TX 77030 ,
  • Exeter Centre of Excellence in Diabetes (EXCEED), University of Exeter Medical School , Exeter EX2 5DW ,
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2024-11-04
Volume
110
Issue
7
Pages
e2191-e2197
ISSN
  • 0021-972X
  • 1945-7197
Cited by
6
References
6
Language
en
Funders
  • National Institute of Health (K23-DK129821, R01-DK124395)
  • National Institute of Diabetes and Digestive and Kidney disease (21/0006328)
  • Diabetes UK (21/0006328)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth. https://app.cochat.ai/papers/10.1210/clinem/dgae770
The paper
Alarcon, G., Nguyen, A., Jones, A., Shields, B., Redondo, M. J., & Tosur, M. (2025). The Maturity-Onset Diabetes of the Young (MODY) Calculator Overestimates MODY Probability in Hispanic Youth. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae770

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.